August 1, 2023
UNC has been selected as a participating site in the RECOVER-VITAL trial. A team of clinicians and researchers from across UNC will contribute to this nationwide work by identifying, treating, and evaluating patients over a six-month study period.
July 11, 2023
Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.
June 27, 2023
A new study by researchers in the UNC School of Medicine, including Meghan Rebuli, PhD, Ilona Jaspers, PhD, and Kevin T. Cao, has found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity.
June 9, 2023
John Buse, MD, PhD, co-authored a study showing that the common diabetes drug metformin substantially decreased the risk of developing long COVID after infection from SARS-CoV-2. The clinical trial was led by researchers at the University of Minnesota.
April 25, 2023
The outbreak of Covid-19 presented many dangers for children, and a new study suggests increased illicit substance ingestions were among them. Lead study author Brittany Raffa, MD, clinical instructor in the Department of Pediatrics at the UNC School of Medicine, talks with CNN Health about the overall stress and parental substance use that contributed to the increase.
February 28, 2023
David Wohl, MD, and Billy Fischer, MD, published an op-ed in the News & Observer, The Charlotte Observer, and McClatchy subsidiaries on their work trying to gain a better understanding of COVID-19 through a largely observation study of thousands of volunteers in North Carolina.
February 22, 2023
NIH-supported studies, including one from UNC School of Medicine’s Emily Pfaff, PhD, co-first author of the study, Coding long COVID: characterizing a new disease through an ICD-10 lens, show variations in long COVID symptoms and diagnostic experiences among different racial and ethnic groups.
December 1, 2022
This research in an infant model was led by researchers from the UNC School of Medicine, Weill Cornell Medicine and University of California, Davis. Kristina De Paris, PhD, professor in the UNC Department of Microbiology & Immunology co-led this project.
November 11, 2022
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD, co-lead, the study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes including recovery from acute illness, symptom rebound, re-infection, and long COVID. Investigators explain the study more in video.
July 5, 2022
The Clinical Trials Unit in the UNC Children’s Research Institute is a site for a national study to assess the efficacy of Paxlovid, a pill to treat COVID in children under 18 at increased risk for severe illness.
July 5, 2022
Ke Cheng, PhD, in the Joint UNC-NCSU Joint Department of Biomedical Engineering, in collaboration with colleagues at UNC-Chapel Hill and Duke University, led the development of the vaccine prototype from proof-of-concept to animal studies.
July 1, 2022
William L. Roper, MD, MPH, former dean of the UNC School of Medicine and CEO of UNC Health, wrote an editorial for the journal Science on "the roles of science and politics in public policy decisions, and the means by which scientific truth is established and updated."